Getting patients to goal: optimal targets and therapies
First published: 21 September 2006
No abstract is available for this article.
References
- 1
Schrader J,
Luders S,
Kulschewski A
et al.
Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study.
Stroke
2005; 36: 1218–26.
- 2
Staessen, JA,
Li Y,
Thijs L,
Wang JG.
Blood pressure reduction and cardiovascular prevention: an update including the 2003–2004 secondary prevention trials.
Hypertens Res
2005; 28: 385–407.
